Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[18F]FB-IL2 Imaging of T Cell Response as Biomarker to Guide Treatment Decisions in Metastatic Melanoma Patients

NCT02922283 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT02922283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02922283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[18F]FB-IL2 Imaging of T Cell Response as Biomarker to Guide Treatment Decisions in Metastatic Melanoma Patients
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Terminated
Start date
October 20, 2016
Completion date
February 14, 2020
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma